Carl Byrnes
Stock Analyst at Northland Capital Markets
(3.40)
# 835
Out of 5,182 analysts
27
Total ratings
55%
Success rate
20%
Average return
Main Sectors:
Stocks Rated by Carl Byrnes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCEL AVITA Medical | Initiates: Outperform | $10 | $5.00 | +100.00% | 1 | Mar 5, 2026 | |
| BWAY BrainsWay | Maintains: Outperform | $9.5 → $12 | $15.68 | -26.66% | 5 | Nov 12, 2025 | |
| SNWV SANUWAVE Health | Initiates: Outperform | $55 | $19.94 | +175.83% | 1 | Sep 3, 2025 | |
| BLFS BioLife Solutions | Maintains: Outperform | $28 → $31 | $22.19 | +39.70% | 2 | Jan 8, 2025 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $13 | $4.60 | +171.74% | 1 | Oct 25, 2024 | |
| MDAI Spectral AI | Initiates: Outperform | $6 | $1.89 | +217.46% | 1 | Aug 12, 2024 | |
| COCH Envoy Medical | Initiates: Outperform | n/a | $0.70 | - | 1 | Dec 21, 2023 | |
| AMRN Amarin Corporation | Maintains: Market Perform | $40 → $25 | $14.62 | +71.00% | 1 | Jul 19, 2023 | |
| CDIO Cardio Diagnostics Holdings | Initiates: Outperform | $240 | $1.97 | +12,082.74% | 1 | May 22, 2023 | |
| VTVT vTv Therapeutics | Maintains: Outperform | $60 → $80 | $37.75 | +111.92% | 4 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $23 | $3.25 | +607.69% | 3 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $30 → $24 | $2.02 | +1,088.12% | 4 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2,000 | $2.58 | +77,419.38% | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.05 | - | 1 | Sep 27, 2017 |
AVITA Medical
Mar 5, 2026
Initiates: Outperform
Price Target: $10
Current: $5.00
Upside: +100.00%
BrainsWay
Nov 12, 2025
Maintains: Outperform
Price Target: $9.5 → $12
Current: $15.68
Upside: -26.66%
SANUWAVE Health
Sep 3, 2025
Initiates: Outperform
Price Target: $55
Current: $19.94
Upside: +175.83%
BioLife Solutions
Jan 8, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $22.19
Upside: +39.70%
TriSalus Life Sciences
Oct 25, 2024
Initiates: Outperform
Price Target: $13
Current: $4.60
Upside: +171.74%
Spectral AI
Aug 12, 2024
Initiates: Outperform
Price Target: $6
Current: $1.89
Upside: +217.46%
Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $0.70
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $40 → $25
Current: $14.62
Upside: +71.00%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $240
Current: $1.97
Upside: +12,082.74%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60 → $80
Current: $37.75
Upside: +111.92%
Jul 26, 2021
Initiates: Outperform
Price Target: $23
Current: $3.25
Upside: +607.69%
May 5, 2021
Maintains: Market Perform
Price Target: $30 → $24
Current: $2.02
Upside: +1,088.12%
Oct 22, 2018
Initiates: Outperform
Price Target: $2,000
Current: $2.58
Upside: +77,419.38%
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $1.05
Upside: -